Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Journal of Immunological Methods|July 5, 2005
Molecular genotyping of the murine H-2K MHC class I alleleMarkus J Hofer, Carmen Finger, Axel Pagenstecher
Human Molecular Genetics|December 18, 2008
A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cellsAxel Pagenstecher, Sonja Stahl, Ulrich Sure, et al.
Biomedical Optics Express|August 12, 2011
Chemoselective imaging of mouse brain tissue via multiplex CARS microscopyChristoph Pohling, Tiago Buckup, Axel Pagenstecher, et al.
Biochimica Et Biophysica Acta|October 20, 2009
Transgenic models for cytokine-induced neurological diseaseIain L Campbell, Markus J Hofer, Axel Pagenstecher
Journal of Neuro-Oncology|August 8, 2002
Malignant germ cell tumors metastatic to the brain: a model for a curable neoplasm? The Freiburg experience and a review of the literatureJohannes Lutterbach, Uwe Spetzger, Susanne Bartelt, et al.
Journal of Medical Genetics|August 26, 2019
Postzygotic mosaicism in cerebral cavernous malformationMatthias Rath, Axel Pagenstecher, Alexander Hoischen, et al.
Journal of Neuroscience Research|December 23, 2003
The TIMPs tango with MMPs and more in the central nervous systemStephen J Crocker, Axel Pagenstecher, Iain L Campbell
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 2, 2003
Lung cancer and Rosai-Dorfman's disease. A clinicopathological studyJohannes Lutterbach, Karl Henne, Axel Pagenstecher, et al.
The American Journal of Pathology|August 28, 2004
Cerebral expression of interleukin-12 induces neurological disease via differential pathways and recruits antigen-specific T cells in virus-infected miceMarkus Hofer, Jürgen Hausmann, Peter Staeheli, et al.
Pageof 8